Warren Huff | Chief Executive Officer |
Colin Meyer | Chief Innovation Officer and Executive Vice President |
Manmeet Soni | Chief Operating Officer and Chief Financial Officer |
Seemi Khan | Chief Medical Officer and Executive Vice President |
Yigal Nochomovitz | Citigroup |
Charles Duncan | Cantor Fitzgerald |
Maury Raycroft | Jefferies |
Annabel Samimy | Stifel |
Brian Skorney | Baird |
Matthew Kaplan | Ladenburg Thalmann |
Thank you for standing by and welcome to Reata Pharmaceuticals Conference Call, during which the company will discuss fourth quarter and full year 2021 financial results and provide an update on its clinical development programs. An audio recording of today's webcast will be available shortly after the call in the Investors section of Reata’s website at reatapharma.com.
Before the company proceeds with its remarks, please note that forward-looking statements disclosure in the company’s press release. There are many factors that could cause results to differ from expectations, including those noted in the company’s SEC filings. On today’s conference call non-GAAP financial measures will be used to help investors understand the business performance.